Audited Results of Medicamen Biotech Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	151.46	172.39	137.88	115.45	110.15
Manufacturing Expenses	5.60	0.08	13.56	12.94	9.20
Personnel Expenses	21.57	22.12	18.57	14.50	8.79
Selling Expenses	0.06	0.18	0.02	0.36	0.01
Administrative Expenses	24.92	32.66	9.77	11.47	5.14
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	134.91	146.42	113.74	91.89	90.57
Operating Profit	16.56	25.97	24.15	23.56	19.58
Other Recurring Income	6.23	2.30	2.46	1.72	0.75
Adjusted PBDIT	22.78	28.27	26.61	25.28	20.33
Financial Expenses	3.05	4.38	2.92	1.40	1.06
Depreciation	6.96	7.01	6.35	5.77	2.52
Other Write offs	0	0	0	0	0
Adjusted PBT	12.77	16.89	17.33	18.10	16.75
Tax Charges	3.33	3.59	2.33	3.20	4.26
Adjusted PAT	9.45	13.30	15	14.91	12.49
Non Recurring Items	0	0	0	0	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	9.45	13.30	15	14.91	12.49
Equity Dividend	0	1.27	1.27	1.22	0.61
Preference Dividend	0	0	0	0	0
Retained Earnings	103.63	94.18	81.85	68.12	54.43

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article